SR-10171

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameSR-10171
Drug Alias NameSR-10171
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ inverse agonists
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsDiabetes Mellitus, Type 2Bone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toledo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of ToledoThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Bone Diseases

Other Information

ATC CodeN/A
Related LinksN/A